Thriving telemedicine tales

The Indian pharmaceutical industry’s share in the global pharmaceutical market is eminent and growing substantially. According to the Indian Economic Survey 2021, India’s pharmaceutical market is expected to have a threefold increase from USD 42 billion in 2021 to USD 120-130 billion by 2030. Within this, a rapidly rising service area is of telemedicine, a subset of telehealth. This is a field in health science comprising of an effective fusion of Information and Communication Technologies (ICT) with Medical Science.

NITI Aayog has projected that the Indian telemedicine market size is set to increase to USD 5.5 billion by 2025, growing at a CAGR of 31%.

In the wake of COVID-19, having safe and remote access to healthcare services came into the limelight. Telemedicine services met this need by providing long-distance patient care through telecommunication channels and thus facilitating patient care operations in accordance with pandemic protocols.

The World Health Organization describes telemedicine as having a “great potential to address some of the challenges faced by both developed and developing countries in providing accessible, cost-effective, high-quality health care services”.

This macro-PDF series studies the opportunities brought about by the rise of Telemedicine, from a People, Development, and Financial angle.

Click here to read more


Thriving telemedicine tales
Thriving telemedicine tales